A study into the use of Abbott's i-STAT device for point-of-care testing in remote health centres in the Northern Territory has found it provides clinical and financial benefits, including the potential to save over $20 million a year after costs.

The Flinders University study, funded by the Emergency Medicine Foundation, assessed both the medical and cost benefits of using on-site pathology testing for acute medical care in six remote health clinics in the NT over six months in 2015.